Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $10.1 Million - $12.6 Million
-55,831 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$148.08 - $206.57 $1.18 Million - $1.65 Million
-7,989 Reduced 12.52%
55,831 $10.7 Million
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $13.7 Million - $17.7 Million
-112,056 Reduced 63.71%
63,820 $9.42 Million
Q2 2020

Aug 03, 2020

SELL
$94.33 - $140.48 $3.15 Million - $4.69 Million
-33,361 Reduced 15.94%
175,876 $21.7 Million
Q1 2020

May 06, 2020

SELL
$84.96 - $109.14 $1.1 Million - $1.42 Million
-12,965 Reduced 5.83%
209,237 $20.2 Million
Q4 2019

Feb 04, 2020

SELL
$73.84 - $93.08 $382,417 - $482,061
-5,179 Reduced 2.28%
222,202 $20.6 Million
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $2.58 Million - $3.21 Million
33,651 Added 17.37%
227,381 $17.4 Million
Q2 2019

Jul 26, 2019

BUY
$54.2 - $85.95 $188,345 - $298,676
3,475 Added 1.83%
193,730 $16.7 Million
Q1 2019

May 07, 2019

BUY
$49.45 - $62.8 $1.47 Million - $1.86 Million
29,666 Added 18.47%
190,255 $11.2 Million
Q4 2018

Feb 13, 2019

BUY
$48.26 - $68.88 $558,464 - $797,079
11,572 Added 7.77%
160,589 $8.47 Million
Q3 2018

Nov 13, 2018

SELL
$46.8 - $58.97 $11.6 Million - $14.6 Million
-247,071 Reduced 62.38%
149,017 $8.26 Million
Q2 2018

Aug 09, 2018

BUY
$35.26 - $47.04 $5.47 Million - $7.3 Million
155,181 Added 64.42%
396,088 $18.6 Million
Q1 2018

May 15, 2018

BUY
$30.92 - $37.27 $26,436 - $31,865
855 Added 0.36%
240,907 $8.72 Million
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $1.47 Million - $1.75 Million
45,066 Added 23.11%
240,052 $8.71 Million
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $7.21 Million - $8.98 Million
194,986
194,986 $7.47 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.